These findings highlighted the potential clinical value of incorporating IFN-α into prognostic assessment and raised the possibility that modulation of IFN signaling could represent a future therapeutic avenue in pulmonary hypertension. The gene discussed is IFNA1; the disease is pulmonary hypertension.